Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and …
A Dohan, B Gallix, B Guiu, K Le Malicot, C Reinhold… - Gut, 2020 - gut.bmj.com
Purpose The objective of this study was to build and validate a radiomic signature to predict
early a poor outcome using baseline and 2-month evaluation CT and to compare it to the …
early a poor outcome using baseline and 2-month evaluation CT and to compare it to the …
[HTML][HTML] Current state of the art imaging approaches for colorectal liver metastasis
B Hazhirkarzar, P Khoshpouri… - … surgery and nutrition, 2020 - ncbi.nlm.nih.gov
One of the most common cancers worldwide, colorectal cancer (CRC) has been associated
with significant morbidity and mortality and therefore represents an enormous burden to the …
with significant morbidity and mortality and therefore represents an enormous burden to the …
The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer
A Muehlberg, JW Holch, V Heinemann, T Huber… - European …, 2021 - Springer
Objectives To investigate the prediction of 1-year survival (1-YS) in patients with metastatic
colorectal cancer with use of a systematic comparative analysis of quantitative imaging …
colorectal cancer with use of a systematic comparative analysis of quantitative imaging …
The potential and emerging role of quantitative imaging biomarkers for cancer characterization
H Tharmaseelan, A Hertel, S Rennebaum… - Cancers, 2022 - mdpi.com
Simple Summary Modern, personalized therapy approaches are increasingly changing
advanced cancer into a chronic disease. Compared to imaging, novel omics methodologies …
advanced cancer into a chronic disease. Compared to imaging, novel omics methodologies …
Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated …
S Wei, Y Han, H Zeng, S Ye, J Cheng, F Chai… - European Journal of …, 2021 - Elsevier
Objective To investigate the capability of a radiomics model, which was designed to identify
histopathologic growth pattern (HGP) of colorectal liver metastases (CRLMs) based on …
histopathologic growth pattern (HGP) of colorectal liver metastases (CRLMs) based on …
Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning
H Tharmaseelan, AK Vellala, A Hertel, F Tollens… - Cancer Imaging, 2023 - Springer
Objectives The goal of this study is to demonstrate the performance of radiomics and CNN-
based classifiers in determining the primary origin of gastrointestinal liver metastases for …
based classifiers in determining the primary origin of gastrointestinal liver metastases for …
[HTML][HTML] Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
J Zhang, H Zhu, L Shen, J Li, X Zhang… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
Objective Currently, pre-treatment prediction of patients with pancreatic neuroendocrine
tumors with liver metastases (PNELM) receiving surufatinib treatment was unsatisfying. Our …
tumors with liver metastases (PNELM) receiving surufatinib treatment was unsatisfying. Our …
Interobserver variability in CT-based morphologic tumor response assessment of colorectal liver metastases
NJ Wesdorp, R Kemna, K Bolhuis… - Radiology: Imaging …, 2022 - pubs.rsna.org
Purpose To evaluate interobserver variability in the morphologic tumor response
assessment of colorectal liver metastases (CRLM) managed with systemic therapy and to …
assessment of colorectal liver metastases (CRLM) managed with systemic therapy and to …
Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the …
T Mazard, C Mollevi, EM Loyer, J Léger, R Chautard… - Cancer Imaging, 2024 - Springer
Abstract Background The Response Evaluation Criteria in Solid Tumors (RECIST) are often
inadequate for the early assessment of the response to cancer therapy, particularly …
inadequate for the early assessment of the response to cancer therapy, particularly …
Enhanced rim on MDCT of colorectal liver metastases: assessment of ability to predict progression-free survival and response to bevacizumab-based chemotherapy
J Cheng, M Qiu, Y Zhang, N Hong… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to evaluate the enhanced rim on the portal venous
phase (PVP) on MDCT as a predictor of 1-year progression-free survival (PFS) and …
phase (PVP) on MDCT as a predictor of 1-year progression-free survival (PFS) and …